1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Radiopharmaceutical Revenue
1.4 Market Analysis by Type
1.4.1 Global Radiopharmaceutical Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Actinium-225
1.4.3 Lutetium-177
1.4.4 Radium-223
1.4.5 Holmium-166
1.4.6 Other
1.5 Market by Application
1.5.1 Global Radiopharmaceutical Market Share by Application: 2021-2026
1.5.2 Oncology
1.5.3 Cardiology
1.5.4 Other
1.6 Study Objectives
1.7 Years Considered
1.8 Overview of Global Radiopharmaceutical Market
1.8.1 Global Radiopharmaceutical Market Status and Outlook (2015-2026)
1.8.2 North America
1.8.3 East Asia
1.8.4 Europe
1.8.5 South Asia
1.8.6 Southeast Asia
1.8.7 Middle East
1.8.8 Africa
1.8.9 Oceania
1.8.10 South America
1.8.11 Rest of the World
2 Market Competition by Manufacturers
2.1 Global Radiopharmaceutical Production Capacity Market Share by Manufacturers (2015-2020)
2.2 Global Radiopharmaceutical Revenue Market Share by Manufacturers (2015-2020)
2.3 Global Radiopharmaceutical Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Radiopharmaceutical Production Sites, Area Served, Product Type
3 Sales by Region
3.1 Global Radiopharmaceutical Sales Volume Market Share by Region (2015-2020)
3.2 Global Radiopharmaceutical Sales Revenue Market Share by Region (2015-2020)
3.3 North America Radiopharmaceutical Sales Volume
3.3.1 North America Radiopharmaceutical Sales Volume Growth Rate (2015-2020)
3.3.2 North America Radiopharmaceutical Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.4 East Asia Radiopharmaceutical Sales Volume
3.4.1 East Asia Radiopharmaceutical Sales Volume Growth Rate (2015-2020)
3.4.2 East Asia Radiopharmaceutical Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.5 Europe Radiopharmaceutical Sales Volume (2015-2020)
3.5.1 Europe Radiopharmaceutical Sales Volume Growth Rate (2015-2020)
3.5.2 Europe Radiopharmaceutical Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.6 South Asia Radiopharmaceutical Sales Volume (2015-2020)
3.6.1 South Asia Radiopharmaceutical Sales Volume Growth Rate (2015-2020)
3.6.2 South Asia Radiopharmaceutical Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.7 Southeast Asia Radiopharmaceutical Sales Volume (2015-2020)
3.7.1 Southeast Asia Radiopharmaceutical Sales Volume Growth Rate (2015-2020)
3.7.2 Southeast Asia Radiopharmaceutical Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.8 Middle East Radiopharmaceutical Sales Volume (2015-2020)
3.8.1 Middle East Radiopharmaceutical Sales Volume Growth Rate (2015-2020)
3.8.2 Middle East Radiopharmaceutical Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.9 Africa Radiopharmaceutical Sales Volume (2015-2020)
3.9.1 Africa Radiopharmaceutical Sales Volume Growth Rate (2015-2020)
3.9.2 Africa Radiopharmaceutical Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.10 Oceania Radiopharmaceutical Sales Volume (2015-2020)
3.10.1 Oceania Radiopharmaceutical Sales Volume Growth Rate (2015-2020)
3.10.2 Oceania Radiopharmaceutical Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.11 South America Radiopharmaceutical Sales Volume (2015-2020)
3.11.1 South America Radiopharmaceutical Sales Volume Growth Rate (2015-2020)
3.11.2 South America Radiopharmaceutical Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.12 Rest of the World Radiopharmaceutical Sales Volume (2015-2020)
3.12.1 Rest of the World Radiopharmaceutical Sales Volume Growth Rate (2015-2020)
3.12.2 Rest of the World Radiopharmaceutical Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
4 North America
4.1 North America Radiopharmaceutical Consumption by Countries
4.2 United States
4.3 Canada
4.4 Mexico
5 East Asia
5.1 East Asia Radiopharmaceutical Consumption by Countries
5.2 China
5.3 Japan
5.4 South Korea
6 Europe
6.1 Europe Radiopharmaceutical Consumption by Countries
6.2 Germany
6.3 United Kingdom
6.4 France
6.5 Italy
6.6 Russia
6.7 Spain
6.8 Netherlands
6.9 Switzerland
6.10 Poland
7 South Asia
7.1 South Asia Radiopharmaceutical Consumption by Countries
7.2 India
7.3 Pakistan
7.4 Bangladesh
8 Southeast Asia
8.1 Southeast Asia Radiopharmaceutical Consumption by Countries
8.2 Indonesia
8.3 Thailand
8.4 Singapore
8.5 Malaysia
8.6 Philippines
8.7 Vietnam
8.8 Myanmar
9 Middle East
9.1 Middle East Radiopharmaceutical Consumption by Countries
9.2 Turkey
9.3 Saudi Arabia
9.4 Iran
9.5 United Arab Emirates
9.6 Israel
9.7 Iraq
9.8 Qatar
9.9 Kuwait
9.10 Oman
10 Africa
10.1 Africa Radiopharmaceutical Consumption by Countries
10.2 Nigeria
10.3 South Africa
10.4 Egypt
10.5 Algeria
10.6 Morocco
11 Oceania
11.1 Oceania Radiopharmaceutical Consumption by Countries
11.2 Australia
11.3 New Zealand
12 South America
12.1 South America Radiopharmaceutical Consumption by Countries
12.2 Brazil
12.3 Argentina
12.4 Columbia
12.5 Chile
12.6 Venezuela
12.7 Peru
12.8 Puerto Rico
12.9 Ecuador
13 Rest of the World
13.1 Rest of the World Radiopharmaceutical Consumption by Countries
13.2 Kazakhstan
14 Sales Volume, Sales Revenue, Sales Price Trend by Type
14.1 Global Radiopharmaceutical Sales Volume Market Share by Type (2015-2020)
14.2 Global Radiopharmaceutical Sales Revenue Market Share by Type (2015-2020)
14.3 Global Radiopharmaceutical Sales Price by Type (2015-2020)
15 Consumption Analysis by Application
15.1 Global Radiopharmaceutical Consumption Volume by Application (2015-2020)
15.2 Global Radiopharmaceutical Consumption Value by Application (2015-2020)
16 Company Profiles and Key Figures in Radiopharmaceutical Business
16.1 Bracco Imaging
16.1.1 Bracco Imaging Company Profile
16.1.2 Bracco Imaging Radiopharmaceutical Product Specification
16.1.3 Bracco Imaging Radiopharmaceutical Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.2 GE Healthcare
16.2.1 GE Healthcare Company Profile
16.2.2 GE Healthcare Radiopharmaceutical Product Specification
16.2.3 GE Healthcare Radiopharmaceutical Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.3 Nordion
16.3.1 Nordion Company Profile
16.3.2 Nordion Radiopharmaceutical Product Specification
16.3.3 Nordion Radiopharmaceutical Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.4 Bayer
16.4.1 Bayer Company Profile
16.4.2 Bayer Radiopharmaceutical Product Specification
16.4.3 Bayer Radiopharmaceutical Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.5 IBA Group
16.5.1 IBA Group Company Profile
16.5.2 IBA Group Radiopharmaceutical Product Specification
16.5.3 IBA Group Radiopharmaceutical Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.6 Mallinckrodt
16.6.1 Mallinckrodt Company Profile
16.6.2 Mallinckrodt Radiopharmaceutical Product Specification
16.6.3 Mallinckrodt Radiopharmaceutical Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.7 Jubilant Pharma
16.7.1 Jubilant Pharma Company Profile
16.7.2 Jubilant Pharma Radiopharmaceutical Product Specification
16.7.3 Jubilant Pharma Radiopharmaceutical Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.8 Lantheus
16.8.1 Lantheus Company Profile
16.8.2 Lantheus Radiopharmaceutical Product Specification
16.8.3 Lantheus Radiopharmaceutical Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.9 Triad Isotopes
16.9.1 Triad Isotopes Company Profile
16.9.2 Triad Isotopes Radiopharmaceutical Product Specification
16.9.3 Triad Isotopes Radiopharmaceutical Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.10 China Isotope & Radiation
16.10.1 China Isotope & Radiation Company Profile
16.10.2 China Isotope & Radiation Radiopharmaceutical Product Specification
16.10.3 China Isotope & Radiation Radiopharmaceutical Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.11 Navidea
16.11.1 Navidea Company Profile
16.11.2 Navidea Radiopharmaceutical Product Specification
16.11.3 Navidea Radiopharmaceutical Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.12 Eli Lilly
16.12.1 Eli Lilly Company Profile
16.12.2 Eli Lilly Radiopharmaceutical Product Specification
16.12.3 Eli Lilly Radiopharmaceutical Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.13 Dongcheng
16.13.1 Dongcheng Company Profile
16.13.2 Dongcheng Radiopharmaceutical Product Specification
16.13.3 Dongcheng Radiopharmaceutical Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.14 Advanced Accelerator Applications
16.14.1 Advanced Accelerator Applications Company Profile
16.14.2 Advanced Accelerator Applications Radiopharmaceutical Product Specification
16.14.3 Advanced Accelerator Applications Radiopharmaceutical Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.15 SIEMENS
16.15.1 SIEMENS Company Profile
16.15.2 SIEMENS Radiopharmaceutical Product Specification
16.15.3 SIEMENS Radiopharmaceutical Production Capacity, Revenue, Price and Gross Margin (2015-2020)
17 Radiopharmaceutical Manufacturing Cost Analysis
17.1 Radiopharmaceutical Key Raw Materials Analysis
17.1.1 Key Raw Materials
17.2 Proportion of Manufacturing Cost Structure
17.3 Manufacturing Process Analysis of Radiopharmaceutical
17.4 Radiopharmaceutical Industrial Chain Analysis
18 Marketing Channel, Distributors and Customers
18.1 Marketing Channel
18.2 Radiopharmaceutical Distributors List
18.3 Radiopharmaceutical Customers
19 Market Dynamics
19.1 Market Trends
19.2 Opportunities and Drivers
19.3 Challenges
19.4 Porter's Five Forces Analysis
20 Production and Supply Forecast
20.1 Global Forecasted Production of Radiopharmaceutical (2021-2026)
20.2 Global Forecasted Revenue of Radiopharmaceutical (2021-2026)
20.3 Global Forecasted Price of Radiopharmaceutical (2015-2026)
20.4 Global Forecasted Production of Radiopharmaceutical by Region (2021-2026)
20.4.1 North America Radiopharmaceutical Production, Revenue Forecast (2021-2026)
20.4.2 East Asia Radiopharmaceutical Production, Revenue Forecast (2021-2026)
20.4.3 Europe Radiopharmaceutical Production, Revenue Forecast (2021-2026)
20.4.4 South Asia Radiopharmaceutical Production, Revenue Forecast (2021-2026)
20.4.5 Southeast Asia Radiopharmaceutical Production, Revenue Forecast (2021-2026)
20.4.6 Middle East Radiopharmaceutical Production, Revenue Forecast (2021-2026)
20.4.7 Africa Radiopharmaceutical Production, Revenue Forecast (2021-2026)
20.4.8 Oceania Radiopharmaceutical Production, Revenue Forecast (2021-2026)
20.4.9 South America Radiopharmaceutical Production, Revenue Forecast (2021-2026)
20.4.10 Rest of the World Radiopharmaceutical Production, Revenue Forecast (2021-2026)
20.5 Forecast by Type and by Application (2021-2026)
20.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2021-2026)
20.5.2 Global Forecasted Consumption of Radiopharmaceutical by Application (2021-2026)
21 Consumption and Demand Forecast
21.1 North America Forecasted Consumption of Radiopharmaceutical by Country
21.2 East Asia Market Forecasted Consumption of Radiopharmaceutical by Country
21.3 Europe Market Forecasted Consumption of Radiopharmaceutical by Countriy
21.4 South Asia Forecasted Consumption of Radiopharmaceutical by Country
21.5 Southeast Asia Forecasted Consumption of Radiopharmaceutical by Country
21.6 Middle East Forecasted Consumption of Radiopharmaceutical by Country
21.7 Africa Forecasted Consumption of Radiopharmaceutical by Country
21.8 Oceania Forecasted Consumption of Radiopharmaceutical by Country
21.9 South America Forecasted Consumption of Radiopharmaceutical by Country
21.10 Rest of the world Forecasted Consumption of Radiopharmaceutical by Country
22 Research Findings and Conclusion
23 Methodology and Data Source
23.1 Methodology/Research Approach
23.1.1 Research Programs/Design
23.1.2 Market Size Estimation
23.1.3 Market Breakdown and Data Triangulation
23.2 Data Source
23.2.1 Secondary Sources
23.2.2 Primary Sources
23.3 Disclaimer